Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

Soricimed Biopharma Inc. - Product Pipeline Analysis, 2014 Update

Regular price $750.00 Sale

Published on Jun 06, 2014 - 22 pages

Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic programs. Its products under clinical development include SOR-C13, SO-C27, SOR-N54, SOR-D01, and SOR-D02. Soricimed's products are used in the treatment of ovarian, breast and prostate cancer, and other cancer types. The company also provides pain management technology. It partners with The Company and the Atlantic Cancer Research Institute, and BC Cancer Agency. The company has a service research agreement with NRC institutions including the NRC Institute for Biological Sciences, NRC Institute for Marine Biosciences, and the NRC Institute for Biodiagnostics. Soricimed is headquartered in Moncton, New Brunswick, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Soricimed Biopharma Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Contents

Table of Contents
Table of Contents
List of Tables
List of Figures
Soricimed Biopharma Inc. Company Snapshot
Soricimed Biopharma Inc. Company Overview
Key Information
Soricimed Biopharma Inc. Pipeline Products and Clinical Trials Overview
Soricimed Biopharma Inc. - Pipeline Analysis Overview
Key Facts
Soricimed Biopharma Inc. - Major Products and Services
Soricimed Biopharma Inc. Pipeline Products by Development Stage
Soricimed Biopharma Inc. Pipeline Products Overview
Diagnostic SOR-D01 Assay - Breast Cancer
Diagnostic SOR-D01 Assay - Breast Cancer Product Overview
Diagnostic SOR-D01 Assay - Ovarian Cancer
Diagnostic SOR-D01 Assay - Ovarian Cancer Product Overview
Diagnostic SOR-D01 Assay - Prostate Cancer
Diagnostic SOR-D01 Assay - Prostate Cancer Product Overview
Diagnostic SOR-D02 Assay - Breast Cancer
Diagnostic SOR-D02 Assay - Breast Cancer Product Overview
Diagnostic SOR-D02 Assay - Ovarian Cancer
Diagnostic SOR-D02 Assay - Ovarian Cancer Product Overview
Diagnostic SOR-D02 Assay - Prostate Cancer
Diagnostic SOR-D02 Assay - Prostate Cancer Product Overview
Soricimed Biopharma Inc. - Key Competitors
Soricimed Biopharma Inc. - Key Employees
Soricimed Biopharma Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Soricimed Biopharma Inc., Recent Developments
Mar 18, 2014: Soricimed Biopharma Announces New VP of R&D
Oct 23, 2012: Soricimed Announces Initiation Of Cancer Diagnostic Study With Potential To Detect Stage One Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Soricimed Biopharma Inc., Key Facts
Soricimed Biopharma Inc. Pipeline Products and Clinical Trials Overview
Soricimed Biopharma Inc. Pipeline Products by Equipment Type
Soricimed Biopharma Inc. Pipeline Products by Indication
Soricimed Biopharma Inc., Key Facts
Soricimed Biopharma Inc., Major Products and Services
Soricimed Biopharma Inc. Number of Pipeline Products by Development Stage
Soricimed Biopharma Inc. Pipeline Products Summary by Development Stage
Diagnostic SOR-D01 Assay - Breast Cancer - Product Status
Diagnostic SOR-D01 Assay - Breast Cancer - Product Description
Diagnostic SOR-D01 Assay - Ovarian Cancer - Product Status
Diagnostic SOR-D01 Assay - Ovarian Cancer - Product Description
Diagnostic SOR-D01 Assay - Prostate Cancer - Product Status
Diagnostic SOR-D01 Assay - Prostate Cancer - Product Description
Diagnostic SOR-D02 Assay - Breast Cancer - Product Status
Diagnostic SOR-D02 Assay - Breast Cancer - Product Description
Diagnostic SOR-D02 Assay - Ovarian Cancer - Product Status
Diagnostic SOR-D02 Assay - Ovarian Cancer - Product Description
Diagnostic SOR-D02 Assay - Prostate Cancer - Product Status
Diagnostic SOR-D02 Assay - Prostate Cancer - Product Description
Soricimed Biopharma Inc., Key Employees

List of Figures
Soricimed Biopharma Inc. Pipeline Products by Equipment Type
Soricimed Biopharma Inc. Pipeline Products by Development Stage

Companies Mentioned:

Soricimed Biopharma Inc.